Registration is open for the 2024 ASRM Scientific Congress & Expo
Clinical trials testing infertility treatments often do not report on the major outcomes of interest to patients and clinicians and the public (such as live birth) nor on the harms, including
The Ethics Committee recommends that in vitro fertilization (IVF) centers develop patient-centered policies regarding requests for futile treatment. In most cases, clear communication can avoid a
A patient request to transfer embryos into her body in a location or at a time when pregnancy is highly unlikely to occur is deemed a request for ‘‘compassionate transfer’’ and often reflects the
Cross-border reproductive care is a growing worldwide phenomenon, raising questions about why assisted reproductive technology patients travel for care, what harms and benefits may result, and
In the United States, economic, racial, ethnic, geographic, and other disparities prevent access to fertility treatment and affect treatment outcomes.
A general overview for good management practices within the endocrinology, andrology, and embryology laboratories in the United States.
Public health crises often require a framework shift in which patient autonomy is balanced with the need to safeguard the health of the community. During such crises, physicians should ensure
The statement concludes that individuals and couples should have access to fertility services irrespective of marital status, sexual orientation, or gender identity.
Scientific research using human embryos advances human health and offspring well-being and provides vital insights into the mechanisms for reproduction and disease. Research involving human embryos
Preimplantation genetic testing for monogenic diseases for adult-onset conditions is ethically permissible for a range of conditions including when the condition is serious and no safe, effective
Displaying 31 to 40 of 1248 records
